-+ 0.00%
-+ 0.00%
-+ 0.00%

OURO MEDICINES - RECEIVES U.S. FDA ORPHAN DRUG DESIGNATION FOR GAMGERTAMIG (OM336) FOR IMMUNE THROMBOCYTOPENIA

Reuters·12/08/2025 13:09:26

Please log in to view news